Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties

Supernatants derived from incubated lymph node cells (LNC) of Lewis rats sensitized to neuroantigen-adjuvant have the capacity to transfer experimental allergic encephalomyelitis (EAE) to syngeneic recipients. Sensitization of donors with guinea pig or rat spinal cord adjuvant by either of two routes of injection was effective in generating EAE supernatant transfer activity (EAE-STA). Despite transfer of typical EAE histopathologic lesions, which were intense and disseminated throughout the neuraxis in some animals, recipient animals invariably remained clinically well. Donor sensitization with purified myelin basic protein of guinea pig or rat origin was conspicuously ineffective in generating EAE-STA. Absorption studies revealed that EAE-STA was diminished after exposure to guinea pig or rat spinal cord or guinea pig or rat kidney, but it was not demonstrably reduced after absorption with neonatal rat spinal cord lacking encephalitogenic activity or with guinea pig or rat myelin basic protein or lysozyme. EAE-STA is stable at -20 degrees C/4 days, -70 degrees C/2 days, 4 degrees C/18 hr, and 56 degrees C/1 hr, and has a m.w. in excess of 100,000 daltons.

Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties

Supernatants derived from incubated lymph node cells (LNC) of Lewis rats sensitized to neuroantigen-adjuvant have the capacity to transfer experimental allergic encephalomyelitis (EAE) to syngeneic recipients. Sensitization of donors with guinea pig or rat spinal cord adjuvant by either of two routes of injection was effective in generating EAE supernatant transfer activity (EAE-STA). Despite transfer of typical EAE histopathologic lesions, which were intense and disseminated throughout the neuraxis in some animals, recipient animals invariably remained clinically well. Donor sensitization with purified myelin basic protein of guinea pig or rat origin was conspicuously ineffective in generating EAE-STA. Absorption studies revealed that EAE-STA was diminished after exposure to guinea pig or rat spinal cord or guinea pig or rat kidney, but it was not demonstrably reduced after absorption with neonatal rat spinal cord lacking encephalitogenic activity or with guinea pig or rat myelin basic protein or lysozyme. EAE-STA is stable at -20 degrees C/4 days, -70 degrees C/2 days, 4 degrees C/18 hr, and 56 degrees C/1 hr, and has a m.w. in excess of 100,000 daltons.

Transfer of experimental allergic encephalomyelitis in Lewis rats using supernates of incubated sensitized lymph node cells

Supernates derived from incubated lymph node cells of Lewis rats sensitized to guinea pig spinal cord-Freund's adjuvant transfer experimental allergic encephalomyelitis (EAE) to syngeneic recipients. EAE supernatant transfer activity (EAE-STA) is not demonstrable in supernates derived from LNC of control donors not sensitized to nervous tissue. After addition of brain antigen to active supernates, EAE-STA is not longer demonstrable.

A technique for separation of canine lymphocytes and their use in the lymphocytotoxic, blastogenic, and rosette assys

When the techniques established for preparing lymphocytes from human blood were applied to canine blood, the resulting preparations were contaminated with significant numbers of other blood cells. A three-step technique is described here for the separation of canine lymphocytes from blood which eliminates most granulocytes, platelets, and erythrocytes. Defibrinated blood is incubated with iron particles to allow phagocytosis by granulocytes. When mixed with Plasmagel, erythrocytes and iron-containing granulocytes sediment rapidly, leaving a lymphocyte-rich supernate plasma which is recovered and banded by centrifugation on a Ficoll-Hypaque gradient. Any erythrocytes remaining in the lymphocyte suspension aspirated from the gradient are eliminated by hypotonic lysis and centrifugation. The resulting preparation, representing 30 per cent recovery of the circulating lymphocytes, contained 85 to 94 per cent lymphocytes with a cell viability of 99 per cent. The functional capacity of the lymphocyte preparation was tested in three assays: 1) lymphoblastic transformation using phytohemagglutinin and pokeweed mitogen, 2) E rosette formation with human erythrocytes showed a mean 5 per cent rosette forming lymphocytes, 3) antibody-mediated lymphocytotoxicity using a canine anti-lymphocyte serum showed titers reproducible within one tube dilution.